Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• All-cause mortality after major gastrointestinal bleeding among patients receiving direct oral anticoagulants: a systematic review and meta-analysis1 passage
• Anticoagulation therapy vs clinical surveillance in isolated subsegmental pulmonary embolism: a systematic review and meta-analysis1 passage
• Antithrombotic therapy after bioprosthetic aortic valve implantation: Warfarin versus aspirin, a randomized controlled trial1 passage
• Apixaban reduces the risk of major and clinically relevant non-major bleeding compared to warfarin in patients with end stage renal disease; a systematic review and meta-analysis of ten studies1 passage
• Current evidence of oral anticoagulant reversal: A systematic review1 passage
• Do computerized clinical decision support systems improve the prescribing of oral anticoagulants? A systematic review1 passage
• Effectiveness and outcome of management strategies for dabigatran- or warfarin-related major bleeding events1 passage
• Effectiveness and safety of short-term anticoagulant regimens after left atrial appendage occlusion: A systematic review and meta-analysis1 passage
• Electronic alerts for ambulatory patients with atrial fibrillation not prescribed anticoagulation: A randomized, controlled trial (AF-ALERT2)1 passage
• Extended thromboprophylaxis following major abdominal/pelvic cancer-related surgery: A systematic review and meta-analysis of the literature1 passage
• External validation of AF-BLEED for predicting major bleeding and for tailoring NOAC dose in AF patients: A post hoc analysis in the ENGAGE AF-TIMI 481 passage
• Iron deficiency anemia as a risk factor associated with stroke and cerebral venous thrombosis in children and adults - a systematic review1 passage
• Meta-analysis on anticoagulation and prevention of thrombosis and mortality among patients with lung cancer1 passage
• Obese patients with atrial fibrillation are more efficiently protected from thrombosis under warfarin or xabans compared to non-obese patients; a systematic review and Meta-analysis of six randomized controlled trials1 passage
• Relationship between type of unprovoked venous thromboembolism and cancer location: An individual patient data meta-analysis1 passage
• Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: A systematic review and meta-analysis1 passage
• Safety and efficacy of apixaban versus low-molecular weight heparin or vitamin-K antagonists for venous thromboembolism treatment in patients with severe renal failure: A systematic review and meta-analysis1 passage
• Safety of antithrombotic drugs in patients with atrial fibrillation and non-end-stage chronic kidney disease: Meta-analysis and systematic review1 passage
• Testosterone replacement therapy and the risk of venous thromboembolism: A systematic review and meta-analysis of randomized controlled trials1 passage
• The incidence of thrombotic events with idarucizumab and andexanet alfa: A systematic review and meta-analysis1 passage
• Timing of vitamin K antagonist re-initiation following intracranial hemorrhage in mechanical heart valves: Systematic review and meta-analysis1 passage
• Warfarin reduces circulating white blood cell count: Post-hoc analysis of two randomized trials1 passage
• Warfarin resumption following anticoagulant-associated intracranial hemorrhage: A systematic review and meta-analysis1 passage